{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:3339",
      "entity_text" : "fenofibrate",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Some other studies indicated that fenofibrate, a drug used for the treatment of hyperlipidemia, could promote the cellular cholesterol efflux by phos phorylating PPARalpha [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-07-28T12:26:19Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T12:24:31Z",
  "trigger" : "promote",
  "evidence" : [ "fenofibrate, a drug used for the treatment of hyperlipidemia, could promote the cellular cholesterol" ],
  "pmc_id" : "6463403",
  "score" : 0
}